Identification
- Composition (DCI)
- bicalutamide
- Manufacturer
- ZENITH PHARMA
- ATC code
- L02BB03
- Presentation
- Boite 10
- Schedule / Reimb.
- A
- Hospital price
- 123.20 MAD
Indications
Cancer de la prostate métastasé Cancer de la prostate métastasé, en association à une castration médicale ou chirurgicale. Cancer de la prostate localement avancé Bicalutamide est indiqué chez les patients atteints d’un cancer de la prostate localement avancé, à haut risque de progression de la maladie, soit en traitement seul soit en traitement adjuvant à la prostatectomie radicale ou à la radiothérapie.
Find an open pharmacy
On-call pharmacies near you
About BICALUTAMIDE ZENITH 50 MG
BICALUTAMIDE ZENITH 50 MG is marketed in Morocco by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of BICALUTAMIDE ZENITH 50 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about BICALUTAMIDE ZENITH 50 MG
Answers to common questions from Moroccan patients about this drug.